GENEVA, June 19 -- CHANGCHUN GENESCIENCE PHARMACEUTICAL CO., LTD. filed a patent application (CN2025/134950) for “TSHR ANTAGONIST COMPOUND, PHARMACEUTICAL COMPOSITION, METHOD FOR PREPARING SAME, AND USE THEREOF”. With publication no. WO/2026/103853, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07D 215/38
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....